Official Title
Uppsala Intensive Care Study of Mechanisms for Organ Dysfunction in Covid-19
Brief Summary

The study aims to investigate organ dysfunction and biomarkers in patients with suspected or verified COVID-19 during intensive care at Uppsala University Hospital.

Detailed Description

Consenting patients with suspected or verified SARS-COV-2 infection, COVID-19, will undergo
daily blood, urine and sputum sampling during their stay in intensive care. Data on organ
dysfunction will be collected through the electronic patient journal and electronic patient
data management system. The collected samples will be analysed for a panel of potential
biomarkers that will be correlated to organ dysfunction and clinical outcome.

Status
Recruiting
Conditions
COVID-19
Organ Dysfunction Syndrome Sepsis
Organ Dysfunction Syndrome, Multiple
Septic Shock
Acute Kidney Injury
Acute Respiratory Distress Syndrome
Eligibility Criteria

Inclusion Criteria:

- Admitted to intensive care

- suspected or verified COVID-19

Exclusion Criteria:

- Pregnancy or breastfeeding

- Under-age

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
Sweden
Locations

Uppsala University Hospital
Uppsala, Sweden

Investigator: Robert Frithiof, MD. PhD.
Contact: 073-6563473
robert.frithiof@surgsci.uu.se

Investigator:

Contacts

Robert Frithiof, MD. PhD.
0736563473
robert.frithiof@surgsci.uu.se

Sara Bülow Anderberg, MD.
0730247414
sarabulow@gmail.com

Investigators

Robert Frithiof, MD. PhD, Principal Investigator
Uppsala University Hospital

Sponsors / Collaborators
Uppsala University
NCT Number
NCT04316884
MeSH Terms
COVID-19
Respiratory Distress Syndrome
Respiratory Distress Syndrome, Newborn
Acute Lung Injury
Acute Kidney Injury
Syndrome
Systemic Inflammatory Response Syndrome
Multiple Organ Failure